DarioHealth (DRIO) Receivables - Other (2015 - 2026)

DarioHealth (DRIO) has reported Receivables - Other for 12 consecutive years, with -$670000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables - Other fell 2.92% year-over-year to -$670000.0; the trailing twelve-month figure through Jun 2026 stood at -$1.0 million (up 75.88% YoY), and the FY2025 full-year result was -$2.7 million, down 58.33% from the prior year.
• Receivables - Other slipped to -$670000.0 in Q2 2026 per DRIO's latest filing, from $75000.0 in the prior quarter.
• Across five years, Receivables - Other topped out at $3.3 million in Q1 2022 and bottomed at -$3.6 million in Q1 2023.
• Historically, Receivables - Other has averaged -$171666.7 across 5 years, with a median of -$259500.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Receivables - Other jumped 1126.42% in 2022, then sank 519.1% in 2024.
• Over 5 years, Receivables - Other stood at $1.9 million in 2022, then slumped by 172.72% to -$1.4 million in 2023, then jumped by 89.55% to -$144000.0 in 2024, then plunged by 60.42% to -$231000.0 in 2025, then tumbled by 190.04% to -$670000.0 in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered -$670000.0, $75000.0, and -$231000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.